Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics
The complexity of coronavirus disease 2019 (COVID-19)’s pathophysiology is such that microbial dysbiosis in the lung and gastrointestinal (GI) microbiota may be involved in its pathogenic process. GI microbiota dysbiosis has been associated with respiratory disorders, including COVID-19, as well as...
| Main Authors: | Frederick Odun-Ayo, Lalini Reddy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-02-01
|
| Series: | Gastroenterology Insights |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2036-7422/13/1/6 |
Similar Items
-
Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment
by: Christina Thoda, et al.
Published: (2023-07-01) -
Correlation between gut microbiota dysbiosis and colorectal cancer: review
by: Zuzanna Chilimoniuk, et al.
Published: (2024-09-01) -
Gut microbiota modulation: a tool for the management of colorectal cancer
by: Yan Wang, et al.
Published: (2022-04-01) -
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
by: Anjana, et al.
Published: (2022-05-01) -
Research Progress on the Improvement Effect and Mechanism of Probiotics on Colorectal Cancer
by: Lijun LIU, et al.
Published: (2022-11-01)